URGN · UroGen Pharma Ltd.
$40.88
-0.58 (-1.40%)
At close · Jul 28
Market Cap
$1.99B
Shares
48.72M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-07-09 | Schoenberg Mark | Officer | 10,000 | 2026-07-09 | RBC CAPITAL MARKETS LLC |
| 2026-06-22 | Schoenberg Mark | Officer | 10,000 | 2026-06-22 | RBC CAPITAL MARKETS LLC |
| 2026-06-09 | Schoenberg Mark | Officer | 5,222 | 2026-06-08 | Oppenheimer & Co. Inc. |
| 2026-05-08 | Schoenberg Mark | Officer | 10,000 | 2026-05-08 | RBC CAPITAL MARKETS LLC |
| 2026-02-03 | Schoenberg Mark | Officer | 13,333 | 2026-02-02 | Oppenheimer & Co. Inc |
| 2025-11-19 | Schoenberg Mark | Officer | 10,000 | 2025-11-19 | RBC CAPITAL MARKETS LLC |
| 2025-09-09 | Schoenberg Mark | Officer | 871 | 2025-09-08 | Oppenheimer & Co. Inc. |
| 2025-09-09 | Smith Jason Drew | Officer | 1,520 | 2025-09-08 | Oppenheimer& Co. |
| 2025-07-29 | Schoenberg Mark | Officer | 5,149 | 2025-07-28 | Oppenheimer & Co. Inc. |
| 2025-07-29 | Smith Jason Drew | Officer | 7,522 | 2025-07-28 | Oppenheimer & Co. Inc. |
| 2025-06-10 | Schoenberg Mark | Officer | 5,162 | 2025-06-09 | Oppenheimer & Co. Inc. |
| 2024-09-10 | Schoenberg Mark | Officer | 859 | 2024-09-09 | Oppenheimer & Co. Inc. |
| 2024-06-11 | Schoenberg Mark | Officer | 5,153 | 2024-06-10 | Oppenheimer & Co. Inc. |
| 2024-03-18 | Schoenberg Mark | Officer | 12,000 | 2024-03-18 | RBC WEALTH MANAGEMENT |
| 2024-02-01 | Schoenberg Mark | Officer | 3,789 | 2024-01-31 | Oppenheimer & Co. Inc. |
| 2024-02-01 | Smith Jason Drew | Officer | 4,993 | 2024-01-31 | Oppenheimer & Co. Inc. |
Showing 1–16 of 16 filings
Key facts
CIK
1668243
CUSIP
M96088105
13F (30d)
24 filings
22 filers
Visit website
Investor relations